
Join to view full profile
101 Merrimac St1st FloorBoston, MA 02114
Phone+1 617-726-4132
Fax+1 617-726-4213
Dr. Niles is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Mass General Brigham/Brigham and Women's Hospital/Massachusetts General HospitalFellowship, Nephrology, 1987 - 1988
Mass General Brigham/Massachusetts General HospitalResidency, Internal Medicine, 1984 - 1986
Johns Hopkins UniversityResidency, Internal Medicine, 1981 - 1984
Oregon Health and Science University School of MedicineClass of 1981
Certifications & Licensure
ME State Medical License 2019 - 2028
MA State Medical License 1985 - 2027
NH State Medical License 2019 - 2027
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Nephrology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 2 Certification LMR - ROE, Massachusetts General Hospital, 2014, 2016-2017
- CMS Meaningful Use Stage 1 Certification LMR - ROE, Massachusetts General Hospital, 2014, 2016-2017
- CMS Meaningful Use Stage 2 Certification 1 Connect BuildYourEMR, Nemo Capital Partners, 2014, 2016-2017
Clinical Trials
Publications & Presentations
PubMed
- Anti-PLA2R antibody levels are associated with thromboembolism risk in individuals with membranous nephropathy and hypoalbuminemia.Ayman Al Jurdi, Christopher El Mouhayyar, Karim Yatim, Orhan Efe, Saif A Muhsin
Journal of Nephrology. 2026-08-14 - Long-term B-cell depletion with rituximab in relapsing, refractory and severe lupus nephritis: a retrospective case series.Qiyu Wang, Orhan Efe, Ayman Al Jurdi, Harish Seethapathy, Reza Zonozi
Clinical Kidney Journal. 2026-06-01 - Should Nephrology Clinical Trials Account for Apolipoprotein L1 Gene Risk Status?Everly Ramos, Andrew L Lundquist, Ayman Al Jurdi, Harish Seethapathy, Anushya Jeyabalan
Clinical Journal of the American Society of Nephrology. 2026-03-01
Press Mentions
When's Best to Re-Dose Rituximab to Maintain ANCA Vasculitis Remission?December 23rd, 2023
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:









